Open innovation networks in Indian pharmaceutical sector

Research output: Contribution to conferencePaper

Abstract

The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected?

The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.

Conference

ConferenceBAM 2015: The 29th Annual Conference of the British Academy of Management Conference
Abbreviated titleBAM 2015
CountryUnited Kingdom
CityPortsmouth
Period8/09/1510/09/15
Internet address

Fingerprint

Innovation
Innovation networks
Pharmaceuticals
Open innovation
Patents
Expertise
Agenda
India
Manufacturing process
System innovation
Drugs
Global market
Process capability
Patent protection

Keywords

  • patent protection
  • open innovation
  • Indian pharmaceutical sector
  • patent regime

Cite this

Bhatnagar, B., Dörfler, V., & MacBryde, J. (2015). Open innovation networks in Indian pharmaceutical sector. Paper presented at BAM 2015: The 29th Annual Conference of the British Academy of Management Conference, Portsmouth, United Kingdom.
Bhatnagar, Bhawani ; Dörfler, Viktor ; MacBryde, Jillian. / Open innovation networks in Indian pharmaceutical sector. Paper presented at BAM 2015: The 29th Annual Conference of the British Academy of Management Conference, Portsmouth, United Kingdom.
@conference{9af0d89e343446ba86e20adf37d59420,
title = "Open innovation networks in Indian pharmaceutical sector",
abstract = "The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected?The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.",
keywords = "patent protection, open innovation, Indian pharmaceutical sector, patent regime",
author = "Bhawani Bhatnagar and Viktor D{\"o}rfler and Jillian MacBryde",
year = "2015",
month = "9",
day = "9",
language = "English",
note = "BAM 2015: The 29th Annual Conference of the British Academy of Management Conference, BAM 2015 ; Conference date: 08-09-2015 Through 10-09-2015",
url = "http://www.bam.ac.uk/bam2015",

}

Bhatnagar, B, Dörfler, V & MacBryde, J 2015, 'Open innovation networks in Indian pharmaceutical sector' Paper presented at BAM 2015: The 29th Annual Conference of the British Academy of Management Conference, Portsmouth, United Kingdom, 8/09/15 - 10/09/15, .

Open innovation networks in Indian pharmaceutical sector. / Bhatnagar, Bhawani; Dörfler, Viktor; MacBryde, Jillian.

2015. Paper presented at BAM 2015: The 29th Annual Conference of the British Academy of Management Conference, Portsmouth, United Kingdom.

Research output: Contribution to conferencePaper

TY - CONF

T1 - Open innovation networks in Indian pharmaceutical sector

AU - Bhatnagar, Bhawani

AU - Dörfler, Viktor

AU - MacBryde, Jillian

PY - 2015/9/9

Y1 - 2015/9/9

N2 - The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected?The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.

AB - The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected?The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.

KW - patent protection

KW - open innovation

KW - Indian pharmaceutical sector

KW - patent regime

UR - http://www.bam.ac.uk/bam2015

M3 - Paper

ER -

Bhatnagar B, Dörfler V, MacBryde J. Open innovation networks in Indian pharmaceutical sector. 2015. Paper presented at BAM 2015: The 29th Annual Conference of the British Academy of Management Conference, Portsmouth, United Kingdom.